• The event was an earnings conference call hosted by Dolat Capital to discuss Q4 FY26 and full year FY26 results, held on June 02, 2026, at 5:30 PM IST.
  • The stated purpose was to discuss financial performance, provide business updates, and detail the recently completed acquisition of Molycop.
  • Management participants included: Mr. Mehul Mohanka (Managing Director & Group Chief Executive Officer), Mr. Pratik Basu Roy (President, Product Management, Global Sales and Marketing), Mr. Shyama Prasad Ganguly (Interim Chief Financial Officer), Mr. Sourav Sen (Chief Executive Officer - Tega McNally Minerals Limited), and from Molycop: Mr. Lance Dawber (Chief Operating Officer) and Mr. Patrick Koley (Chief Financial Officer).
  • The transcript was made available on the company's website at https://www.tegaindustries.com/investor/#stock-exchange as part of regulatory compliance.
  • The company did not explicitly state that no unpublished price sensitive information (UPSI) would be shared during the call.

Financial Highlights Discussed

  • Full Year FY26 Performance: Consolidated revenue stood at INR 17,736 million, representing 5% YoY growth. Adjusted EBITDA (before exceptional items) was INR 3,967 million with margins of 22%. Exceptional items included Molycop acquisition costs (INR 775 million) and labour code impact (INR 64 million).
  • Q4 FY26 Performance: Total income was INR 5,633 million with adjusted EBITDA of INR 1,632 million (29% margin).
  • Business Segment Performance: Consumables contributed 84% of revenue (flat YoY), while Equipment contributed 16% (25% growth YoY to INR 2,688 million).
  • Order Book: Strong order book of INR 12,060 million as of March 31, 2026, with INR 9,060 million executable within 12 months (18% YoY increase).
  • Gross Margins: Remained healthy at 60% despite raw material volatility.
  • Molycop Acquisition: Successfully completed on June 1, 2026. Adds $838 million debt (reduced from initial $1,050+ million). Parent company (Tega) took additional INR 1,500 crores debt for acquisition financing.
  • Molycop Financials: FY26 revenue estimated at $1,539 million with 1% growth and 12% EBITDA margin. Maintenance capex budgeted at $20 million for FY27.
  • Guidance: Consumables business expected to maintain 15% CAGR; Equipment business expected 25% growth similar to FY26; Molycop expected 3% growth in FY27.
  • Capex Plans: Chile plant commissioning expected by early Q3 FY27 ($25-30 million capex); sustaining capex of INR 50-60 crores across geographies.

Additional Notes Section

  • The document is a transcript of the earnings conference call submitted as a regulatory filing to BSE and NSE.
  • The transcript included detailed Q&A session with analysts covering integration plans, growth outlook, margin profiles, and segment-specific performance.
  • Logistical disruptions in Q4 (vessel connectivity and container availability issues) were cited as reasons for flat consumables revenue, with finished goods inventory increasing by approximately INR 50 crores.
  • Additional acquisition-related costs of approximately $30 million are expected in Q1 FY27 for debt refinancing and preference costs.
  • The company maintains EBITDA margin guidance of 21-22% for the blended business (ex-Molycop).